Eye tracking and gating system for proton therapy of orbital tumors

Dongho Shin, Seung Hoon Yoo, Sung Ho Moon, Myonggeun Yoon, Se Byeong Lee, Sung Yong Park

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: A new motion-based gated proton therapy for the treatment of orbital tumors using real-time eye-tracking system was designed and evaluated. Methods: We developed our system by image-pattern matching, using a normalized cross-correlation technique with LabVIEW 8.6 and Vision Assistant 8.6 (National Instruments, Austin, TX). To measure the pixel spacing of an image consistently, four different calibration modes such as the point-detection, the edge-detection, the line-measurement, and the manual measurement mode were suggested and used. After these methods were applied to proton therapy, gating was performed, and radiation dose distributions were evaluated. Results: Moving phantom verification measurements resulted in errors of less than 0.1 mm for given ranges of translation. Dosimetric evaluation of the beam-gating system versus nongated treatment delivery with a moving phantom shows that while there was only 0.83 mm growth in lateral penumbra for gated radiotherapy, there was 4.95 mm growth in lateral penumbra in case of nongated exposure. The analysis from clinical results suggests that the average of eye movements depends distinctively on each patient by showing 0.44 mm, 0.45 mm, and 0.86 mm for three patients, respectively. Conclusions: The developed automatic eye-tracking based beam-gating system enabled us to perform high-precision proton radiotherapy of orbital tumors.

Original languageEnglish
Pages (from-to)4265-4273
Number of pages9
JournalMedical Physics
Volume39
Issue number7
DOIs
Publication statusPublished - 2012 Jul 1

Fingerprint

Proton Therapy
Radiotherapy
Eye Movements
Growth
Calibration
Protons
Neoplasms
Radiation
Therapeutics
austin

Keywords

  • eye tracking
  • orbital tumors
  • proton
  • proton gating

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Shin, D., Yoo, S. H., Moon, S. H., Yoon, M., Lee, S. B., & Park, S. Y. (2012). Eye tracking and gating system for proton therapy of orbital tumors. Medical Physics, 39(7), 4265-4273. https://doi.org/10.1118/1.4729708

Eye tracking and gating system for proton therapy of orbital tumors. / Shin, Dongho; Yoo, Seung Hoon; Moon, Sung Ho; Yoon, Myonggeun; Lee, Se Byeong; Park, Sung Yong.

In: Medical Physics, Vol. 39, No. 7, 01.07.2012, p. 4265-4273.

Research output: Contribution to journalArticle

Shin, D, Yoo, SH, Moon, SH, Yoon, M, Lee, SB & Park, SY 2012, 'Eye tracking and gating system for proton therapy of orbital tumors', Medical Physics, vol. 39, no. 7, pp. 4265-4273. https://doi.org/10.1118/1.4729708
Shin, Dongho ; Yoo, Seung Hoon ; Moon, Sung Ho ; Yoon, Myonggeun ; Lee, Se Byeong ; Park, Sung Yong. / Eye tracking and gating system for proton therapy of orbital tumors. In: Medical Physics. 2012 ; Vol. 39, No. 7. pp. 4265-4273.
@article{6753830df6c646fa91f3b96d3e577a72,
title = "Eye tracking and gating system for proton therapy of orbital tumors",
abstract = "Purpose: A new motion-based gated proton therapy for the treatment of orbital tumors using real-time eye-tracking system was designed and evaluated. Methods: We developed our system by image-pattern matching, using a normalized cross-correlation technique with LabVIEW 8.6 and Vision Assistant 8.6 (National Instruments, Austin, TX). To measure the pixel spacing of an image consistently, four different calibration modes such as the point-detection, the edge-detection, the line-measurement, and the manual measurement mode were suggested and used. After these methods were applied to proton therapy, gating was performed, and radiation dose distributions were evaluated. Results: Moving phantom verification measurements resulted in errors of less than 0.1 mm for given ranges of translation. Dosimetric evaluation of the beam-gating system versus nongated treatment delivery with a moving phantom shows that while there was only 0.83 mm growth in lateral penumbra for gated radiotherapy, there was 4.95 mm growth in lateral penumbra in case of nongated exposure. The analysis from clinical results suggests that the average of eye movements depends distinctively on each patient by showing 0.44 mm, 0.45 mm, and 0.86 mm for three patients, respectively. Conclusions: The developed automatic eye-tracking based beam-gating system enabled us to perform high-precision proton radiotherapy of orbital tumors.",
keywords = "eye tracking, orbital tumors, proton, proton gating",
author = "Dongho Shin and Yoo, {Seung Hoon} and Moon, {Sung Ho} and Myonggeun Yoon and Lee, {Se Byeong} and Park, {Sung Yong}",
year = "2012",
month = "7",
day = "1",
doi = "10.1118/1.4729708",
language = "English",
volume = "39",
pages = "4265--4273",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "7",

}

TY - JOUR

T1 - Eye tracking and gating system for proton therapy of orbital tumors

AU - Shin, Dongho

AU - Yoo, Seung Hoon

AU - Moon, Sung Ho

AU - Yoon, Myonggeun

AU - Lee, Se Byeong

AU - Park, Sung Yong

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Purpose: A new motion-based gated proton therapy for the treatment of orbital tumors using real-time eye-tracking system was designed and evaluated. Methods: We developed our system by image-pattern matching, using a normalized cross-correlation technique with LabVIEW 8.6 and Vision Assistant 8.6 (National Instruments, Austin, TX). To measure the pixel spacing of an image consistently, four different calibration modes such as the point-detection, the edge-detection, the line-measurement, and the manual measurement mode were suggested and used. After these methods were applied to proton therapy, gating was performed, and radiation dose distributions were evaluated. Results: Moving phantom verification measurements resulted in errors of less than 0.1 mm for given ranges of translation. Dosimetric evaluation of the beam-gating system versus nongated treatment delivery with a moving phantom shows that while there was only 0.83 mm growth in lateral penumbra for gated radiotherapy, there was 4.95 mm growth in lateral penumbra in case of nongated exposure. The analysis from clinical results suggests that the average of eye movements depends distinctively on each patient by showing 0.44 mm, 0.45 mm, and 0.86 mm for three patients, respectively. Conclusions: The developed automatic eye-tracking based beam-gating system enabled us to perform high-precision proton radiotherapy of orbital tumors.

AB - Purpose: A new motion-based gated proton therapy for the treatment of orbital tumors using real-time eye-tracking system was designed and evaluated. Methods: We developed our system by image-pattern matching, using a normalized cross-correlation technique with LabVIEW 8.6 and Vision Assistant 8.6 (National Instruments, Austin, TX). To measure the pixel spacing of an image consistently, four different calibration modes such as the point-detection, the edge-detection, the line-measurement, and the manual measurement mode were suggested and used. After these methods were applied to proton therapy, gating was performed, and radiation dose distributions were evaluated. Results: Moving phantom verification measurements resulted in errors of less than 0.1 mm for given ranges of translation. Dosimetric evaluation of the beam-gating system versus nongated treatment delivery with a moving phantom shows that while there was only 0.83 mm growth in lateral penumbra for gated radiotherapy, there was 4.95 mm growth in lateral penumbra in case of nongated exposure. The analysis from clinical results suggests that the average of eye movements depends distinctively on each patient by showing 0.44 mm, 0.45 mm, and 0.86 mm for three patients, respectively. Conclusions: The developed automatic eye-tracking based beam-gating system enabled us to perform high-precision proton radiotherapy of orbital tumors.

KW - eye tracking

KW - orbital tumors

KW - proton

KW - proton gating

UR - http://www.scopus.com/inward/record.url?scp=84864227793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864227793&partnerID=8YFLogxK

U2 - 10.1118/1.4729708

DO - 10.1118/1.4729708

M3 - Article

C2 - 22830760

AN - SCOPUS:84864227793

VL - 39

SP - 4265

EP - 4273

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 7

ER -